AI at the bedside: First-ever Extubation Decision Support Product approved in Canada

OBIO NewsOntario Industry Updates
Written By Arsheen Kaur

Canadian medical technology company, Therapeutic Monitoring Systems Inc. (TMS), recently announced Health Canada approval of their first clinical decision support tool - Extubation Advisor (EA), a Class III Medical Device, via its commercial software manufacturing partner OBS Medical Ltd.

Therapeutic Monitoring Systems is an OBIO® member and an alumnus of our EAHN™ and HealthMINT™ programs.

Arsheen Kaur
Previous

Centre Hospitalier de l'Université de Montréal (CHUM) partners with A.I. VALI to evaluate an artificial intelligence platform for real-time endoscopy image analysis

Next

FluidAI Medical announces $15M in Series A funding for AI-driven postoperative monitor at HLTH 2023